626 Financial’s AbbVie ABBV Stock Holding History

626 Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.18M	Hold	4,673	–	–	0.46%	38
2026 Q1	$1.02M	Hold	4,673	–	–	0.45%	43
2025 Q4	$1.07M	Hold	4,673	–	–	0.46%	38
2025 Q3	$1.08M	Buy	4,673 +7	+0.2%	+$1.43K	0.47%	38
2025 Q2	$866K	Sell	4,666 -38	-0.8%	-$7.06K	0.41%	42
2025 Q1	$986K	Hold	4,704	–	–	0.51%	36
2024 Q4	$836K	Hold	4,704	–	–	0.45%	43
2024 Q3	$929K	Hold	4,704	–	–	0.51%	41
2024 Q2	$807K	Hold	4,704	–	–	0.47%	44
2024 Q1	$857K	Sell	4,704 -198	-4%	-$34.1K	0.52%	38
2023 Q4	$760K	Sell	4,902 -403	-8%	-$58.8K	0.5%	40
2023 Q3	$791K	Hold	5,305	–	–	0.54%	41
2023 Q2	$715K	Sell	5,305 -494	-9%	-$72.4K	0.46%	41
2023 Q1	$924K	Hold	5,799	–	–	0.61%	33
2022 Q4	$937K	Hold	5,799	–	–	0.65%	36
2022 Q3	$778K	Hold	5,799	–	–	0.63%	38
2022 Q2	$890K	Hold	5,799	–	–	0.67%	30
2022 Q1	$940K	Sell	5,799 -74	-1%	-$10.7K	0.6%	34
2021 Q4	$795K	Buy	+5,873	New	+$694K	0.49%	40
2021 Q1	$940K	Buy	+5,799	New	+$620K	0.6%	34

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

626 Financial's ABBV Position: Q2 2026 in Review

626 Financial held its AbbVie (ABBV) position steady in Q2 2026 at 4,673 shares worth $1.18M. The position accounts for 0.46% of the portfolio, ranked #38.

626 Financial first reported a position in ABBV in Q1 2021 and has held it in 20 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

626 Financial held 4,673 shares of AbbVie worth $1.18M as of Q2 2026.
626 Financial left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.46% of 626 Financial's portfolio in Q2 2026, its #38 holding.
626 Financial first reported a position in AbbVie in Q1 2021 and has held it in 20 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 626 Financial's 13F filing for Q2 2026, filed 27 Jul 2026.